Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image euros

Experts Debate Whether Money Should Have a Place Organ Donation

By Richard Balagtas

The organ donation industry rakes in some $20 billion every year. Non-profit companies, such as Gift of Life and CORE, are key contributors. According to their 2012 tax forms, these two non-profits have a combined value of almost $100 million. While money is important for building and growing an industry, one wonders how much difference this capital would make if it were invested directly into saving lives instead of directly into the savings accounts of company executives. Six CORE employees and eight Gift of Life employees each earn more than $100,000 per year. The companies’ CEOs earn annual salaries of around $300,000 each.

While federal law prohibits people from receiving payment for donating their organs, individuals are reimbursed for the cost of surgery; these reimbursements often total in the hundreds of millions.

Michele Bratcher Goodwin, Chancellor’s Professor of Law at UC Irvine, finds it curious that the moral debates surrounding a legal market for organs don’t extend to situations involving sperm or ova donations. She also notes that, due to the size of the tissue market in the United States, it is extremely likely that every individual will come in contact with human tissue that has been “marketed” for implementation. For example, the white amalgam, or “filling,” that you receive at the dental office is actually human bone that once was part of someone’s body.

“With some companies making millions off of donated tissues and nonprofits building multimillion dollar reserves, is it time to revaluate the law?” she asks.

Read the full article here.

By Admin@gbi|2016-06-15T18:18:24+00:00February 5th, 2015|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Gallery

    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official

  • Study suggests Pfizer vaccine works against virus variant
    Study suggests Pfizer vaccine works against virus variant
    Gallery

    Study suggests Pfizer vaccine works against virus variant

  • Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Gallery

    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says

  • First shipments of Pfizer vaccine to be delivered December 15
    First shipments of Pfizer vaccine to be delivered December 15
    Gallery

    First shipments of Pfizer vaccine to be delivered December 15

  • Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Gallery

    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area